New product intros [aducanumab-avwa, aviptadil, belumosudil mesylate, belzutifan (first-in-class), disitamab vedotin, dostarlimab-gxly, fuzuloparib, hetrombopag olamine, ibrexafungerp, imeglimin hydrochloride (first-in-class), infigratinib, Kconvac].

• Localización: Medicamentos de actualidad = Drugs of today, ISSN 1699-3993, Vol. 57, Nº. 10, 2021, págs. 645-648
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • New product intros [aducanumab-avwa, aviptadil, belumosudil mesylate, belzutifan (first-in-class), disitamab vedotin, dostarlimab-gxly, fuzuloparib, hetrombopag olamine, ibrexafungerp, imeglimin hydrochloride (first-in-class), infigratinib, Kconvac].